Lauren White - Jun 21, 2021 Form 4 Insider Report for C4 Therapeutics, Inc. (CCCC)

Role
Chief Financial Officer
Signature
/s/ Shoaib Ghias, Attorney-in-Fact
Stock symbol
CCCC
Transactions as of
Jun 21, 2021
Transactions value $
$0
Form type
4
Date filed
6/21/2021, 08:22 PM
Next filing
Feb 16, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CCCC Stock Option (Right to Buy) Award $0 +136K $0.00 136K Jun 21, 2021 Common Stock 136K $38.49 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of this option shall vest and become exercisable on June 21, 2022, with the remainder vesting in 36 equal monthly installments thereafter.